Literature DB >> 3054559

The natural history of impaired glucose tolerance in the Pima Indians.

M F Saad1, W C Knowler, D J Pettitt, R G Nelson, D M Mott, P H Bennett.   

Abstract

Among 384 Pima Indians with impaired glucose tolerance according to World Health Organization criteria who were followed for 1.6 to 11.5 years (median, 3.3), non-insulin-dependent diabetes mellitus (NIDDM) developed in 118 (31 percent), glucose tolerance remained impaired in 100 (26 percent), and glucose tolerance returned to normal in 166 (43 percent). The cumulative incidence of NIDDM was 25 and 61 percent at 5 and 10 years, respectively. The risk of development of diabetes was 6.3 times (95 percent confidence interval, 3.8 to 10.6) as high as in a normoglycemic control group (n = 752). Variables predicting deterioration to NIDDM were age up to the age of 40, after which increasing age had a beneficial effect; higher plasma glucose levels during fasting and after carbohydrate loading; and higher serum insulin levels after fasting and lower levels after carbohydrate loading, suggesting that insulin resistance and decreased beta-cell responsiveness are important determinants of the clinical outcome of impaired glucose tolerance. Obese subjects had 2.9 times (95 percent confidence interval, 2.0 to 10.9) the incidence of NIDDM as the nonobese. Obesity was not, however, predictive of progression to NIDDM after an adjustment for plasma glucose and serum insulin levels. We conclude that in this population approximately one fourth of subjects with impaired glucose tolerance have NIDDM at five years and two thirds at 10 years (approximately one third revert to normal) and that age and plasma glucose and insulin levels are the best predictors of clinical outcome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3054559     DOI: 10.1056/NEJM198812083192302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  94 in total

1.  The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.

Authors: 
Journal:  Diabetes Care       Date:  2000-11       Impact factor: 19.112

Review 2.  Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

3.  Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects.

Authors:  L Mykkänen; S M Haffner; J Kuusisto; K Pyörälä; C N Hales; M Laakso
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

Review 4.  Treatment of prediabetes.

Authors:  Mustafa Kanat; Ralph A DeFronzo; Muhammad A Abdul-Ghani
Journal:  World J Diabetes       Date:  2015-09-25

5.  Heterogeneous glycaemic and insulinaemic responses to oral glucose in non-diabetic men: interactions between duration of obesity, body fat distribution and family history of diabetes mellitus.

Authors:  S Lemieux; J P Després; A Nadeau; D Prud'homme; A Tremblay; C Bouchard
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

Review 6.  The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.

Authors:  S C Bain; P M Dodson
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

7.  Hypertension and non-insulin dependent diabetes.

Authors:  J S Yudkin
Journal:  BMJ       Date:  1991-09-28

Review 8.  Type 2 diabetes mellitus in pediatrics: a new challenge.

Authors:  Michelle Van Name; Nicola Santoro
Journal:  World J Pediatr       Date:  2013-11-14       Impact factor: 2.764

9.  The association of the insulin resistance syndrome with impaired glucose tolerance and NIDDM in the Japanese general population: the Hisayama study.

Authors:  T Ohmura; K Ueda; Y Kiyohara; I Kato; H Iwamoto; K Nakayama; K Nomiyama; S Ohmori; T Yoshitake; A Shinkawa
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 10.  Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J P Felber; E Haesler; E Jéquier
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.